$85.21 USD (0.00% 24h)
As of 2026-09-15 15:36 UTC. Source: The Crypto App market data. USD snapshot, not a live tick.
No REW-specific catalyst is visible in the latest headlines.
Edwards Lifesciences engages in the R&D and physical manufacturing of structural heart medical devices. The core product is artificial heart valve systems primarily aimed at transcatheter aortic valve replacement (TAVR). The company precision-processes medical-grade animal tissue and metal stents, assembling them into physical devices implantable in the human body. The strictly sterilized medical consumables are…